Paperdoi:10.2196/86621
Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study
JMIR Cardio
TL;DR
Prospective proof-of-concept (n=20 cardiac cases + 1 healthy control) reconstructing 12-lead ECG from sequential smartwatch recordings via RR-interval-guided temporal resampling for aVR/aVL/aVF plus precordial smartwatch leads. Visual correlation specialty means 78.1–91.3% (mean 81.1); axis agreement high; small mean differences on HR/PR; larger deltas on P-wave/QT/QTc. Sequential acquisition — not simultaneous waveform equivalence.
- Subjects: 20
Abstract
Background
Smartwatches have significantly expanded personal health monitoring capabilities; however, their application in comprehensive cardiac assessment remains limited by single-lead electrocardiogram (ECG) acquisition. The inability to directly obtain augmented limb leads represents a major limitation for the evaluation of ischemic and arrhythmogenic conditions.
Objective
This study aimed to present and preliminarily evaluate a methodology for generating augmented limb leads (augmented voltage right [aVR], augmented voltage left [aVL], and augmented voltage foot [aVF]) from sequential smartwatch recordings through signal synchronization and RR interval alignment, and to combine this approach with precordial smartwatch recordings to reconstruct a full 12-lead ECG in a proof-of-concept setting.
Methods
A signal-processing framework was developed to preserve ECG morphology across sequential smartwatch lead recordings. The method is based on RR interval–guided temporal resampling, enabling interlead synchronization and analytical reconstruction of augmented limb leads. A prospective proof-of-concept clinical validation was conducted in 20 cases with diverse cardiac pathologies, including 1 healthy control. Smartwatch-derived ECGs were compared with standard 12-lead ECGs. Evaluation included expert-based clinical interpretation by 85 health care professionals and objective quantitative analysis of key electrocardiographic parameters, including heart rate, PR interval, QRS duration, QT interval, QTc, RR interval, P-wave duration, and PP interval. Mean values, SDs, and intermethod differences were calculated to assess agreement and variability.
Results
Reconstruction of a 12-lead ECG from smartwatch-acquired signals was successfully achieved in all cases. Visual correlation scores between smartwatch-derived and conventional ECGs ranged from 78.1% to 91.3% across specialty-level means (mean 81.1, SD 22.7), indicating high perceived concordance; individual case-level scores ranged more widely, from 47.0% to 96.3%. Evaluator-perceived axis agreement reached 95.4% across all cases, while the investigators’ direct axis measurements showed complete concordance in all cases. Quantitative analysis demonstrated small mean differences between modalities, with particularly high agreement observed in structurally stable parameters such as heart rate (mean 77.2, SD 22.3 vs mean 75.9, SD 23.1 bpm; Δ=1.3 bpm) and PR interval (mean 176.2, SD 29.1 vs mean 180.8, SD 19.8 ms; Δ=−4.6 ms). Greater variability was observed in atrial activation parameters such as P-wave duration (Δ=−13.3 ms) and time-dependent parameters such as QT (Δ=−19.2 ms) and QTc (Δ=−12.7 ms).
Conclusions
This proof-of-concept study demonstrates the feasibility of reconstructing a full 12-lead ECG from smartwatch-derived signals using a synchronization-based approach. The results demonstrated generally small mean differences between conventional and smartwatch-derived ECG measurements, although larger interval differences were observed in some individual cases. Importantly, due to the sequential nature of signal acquisition, the proposed methodology does not aim to achieve direct waveform equivalence but rather clinically meaningful agreement in electrocardiographic parameters. These findings support the potential of smartwatches as accessible tools for advanced cardiac monitoring and broaden their applicability beyond single-lead screening.
Verbatim from the publisher's DOI record (opens in a new tab) · Abstract as deposited by the publisher with Crossref; © the authors/publisher
Results on ChatPPG leaderboards
All leaderboardsNo results from this paper on ChatPPG leaderboards yet. Browse the leaderboards.
Tasks & signals
Tasks
Signals
Keywords
How it works
Cite this paper
Suárez, M. B., Plaza-Seco, C., Francés, R. M., Salinas, G. L. A., & Blanco-Velasco, M. (2026). Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study. JMIR Cardio. https://doi.org/10.2196/86621
Suárez, Mauro Buelga, Carmen Plaza-Seco, Roberto Matía Francés, Gonzalo Luis Alonso Salinas, and Manuel Blanco-Velasco. 2026. "Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study." JMIR Cardio. https://doi.org/10.2196/86621.
Suárez, M. B., Plaza-Seco, C., Francés, R. M., Salinas, G. L. A. and Blanco-Velasco, M. (2026) 'Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study', JMIR Cardio. doi: 10.2196/86621.
Suárez, Mauro Buelga, et al. "Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study." JMIR Cardio, 2026. https://doi.org/10.2196/86621.
M. B. Suárez, C. Plaza-Seco, R. M. Francés, G. L. A. Salinas, and M. Blanco-Velasco, "Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study," JMIR Cardio, 2026, doi: 10.2196/86621.
@article{suarez2026generation,
title = {{Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study}},
author = {Suárez, Mauro Buelga and Plaza-Seco, Carmen and Francés, Roberto Matía and Salinas, Gonzalo Luis Alonso and Blanco-Velasco, Manuel},
year = {2026},
journal = {JMIR Cardio},
doi = {10.2196/86621}
}Added to the ChatPPG research hub